A clinical trial in which volunteers were infected with dengue virus six months after receiving either an experimental dengue vaccine or a placebo injection yielded starkly contrasting results. All 21 ...

A US federally funded Phase II challenge trial investigating AbViro’s sole pipeline candidate, AV1, will see 84 patients infected with dengue virus. The US National Institutes of Health (NIH) has ...

The novel use of a human challenge model has shown that a live attenuated dengue virus vaccine not only induces antibodies to all four strains of dengue but also effectively prevented the most ...

Oct 20 (Reuters) - A pill for dengue fever developed by Johnson & Johnson (JNJ.N), opens new tab appeared to protect against a form of the virus in a handful of patients in a small human challenge ...

Please provide your email address to receive an email when new articles are posted on . A dengue vaccine currently in phase 3 development was 100% effective at preventing the disease, according to the ...

Newly published data reveal in greater depth the problem Sanofi Pasteur’s Dengvaxia vaccine poses to children who have never experienced a dengue infection. The findings, first revealed by the company ...

is a freelance science journalist, podcast host, comics artist, and TV host. Every year, mosquito bites cause up to 400 million dengue virus infections — but an experimental vaccine developed by the ...

A clinical trial in which volunteers were infected with dengue virus six months after receiving either an experimental dengue vaccine developed by scientists from the National Institutes of Health ...